These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34609755)

  • 1. Sun Sign in the Ultrasound Diagnosis and Activity Assessment of Morphea.
    Salgueiro C; Baeza J; Moll C; Alfaro-Sepúlveda D; Mellado G; Villaseca-Hernández M; Vera-Kellet C; Wortsman X
    J Ultrasound Med; 2022 Jul; 41(7):1817-1824. PubMed ID: 34609755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity assessment in morphea using color Doppler ultrasound.
    Wortsman X; Wortsman J; Sazunic I; Carreño L
    J Am Acad Dermatol; 2011 Nov; 65(5):942-8. PubMed ID: 21550692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea.
    Parra-Cares J; Wortsman X; Alfaro-Sepúlveda D; Mellado-Francisco G; Ramírez-Cornejo C; Vera-Kellet C
    J Cutan Med Surg; 2023; 27(5):454-460. PubMed ID: 37533149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound Morphea Activity Scoring (US-MAS): Modified US-MAS.
    Wortsman X; Vera-Kellet C
    J Ultrasound Med; 2023 Oct; 42(10):2447-2450. PubMed ID: 37129178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonography as an auxiliary diagnostic tool for morphea profunda: A case report.
    Hsieh M; Tokoro S; Ugajin T; Namiki T; Miura K; Yokozeki H
    J Dermatol; 2019 Jul; 46(7):626-630. PubMed ID: 31149739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatologic ultrasound in the management of childhood linear morphea.
    Laverde-Saad A; Lopez-Negrete E; Roustan G; Alfagemeb F
    Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of imaging in morphea assessment: A review of the literature.
    Khorasanizadeh F; Kalantari Y; Etesami I
    Skin Res Technol; 2023 Jul; 29(7):e13410. PubMed ID: 37522502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea).
    Hoffmann K; Gerbaulet U; el-Gammal S; Altmeyer P
    Acta Derm Venereol Suppl (Stockh); 1991; 164():3-16. PubMed ID: 1812687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma).
    Nezafati KA; Cayce RL; Susa JS; Setiawan AT; Tirkes T; Bendeck SE; Jacobe HT
    Arch Dermatol; 2011 Sep; 147(9):1112-5. PubMed ID: 21931057
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the CAV1 gene in clinically, sonographically and histologically proven morphea patients.
    Wortsman X; Ma L; Chung WK; Wortsman J
    Exp Dermatol; 2015 Sep; 24(9):718-20. PubMed ID: 25940406
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of dermoscopy and high-frequency ultrasound in staging morphea.
    Zhang S; Zhu QL; Xiao MS; Liu J
    J Dermatol; 2023 Apr; 50(4):511-517. PubMed ID: 36420557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphea After Liposuction Ultrasonography.
    Araneda-Ortega P; Poblete-Villacorta MJ; Muñoz-López C; Vera-Kellet C; Wortsman X
    J Ultrasound Med; 2022 Oct; 41(10):2629-2635. PubMed ID: 35023212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency ultrasound evaluation of morphea: Retrospective analytical study.
    Yazdanparast T; Mohseni A; Dehghan KS; Delavar S; Firooz A
    Skin Res Technol; 2024 Jul; 30(7):e13818. PubMed ID: 38924131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of epidermal atrophy in localized scleroderma (morphea).
    Serup J
    Dermatologica; 1986; 172(4):205-8. PubMed ID: 3519301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea.
    Wortsman X
    J Scleroderma Relat Disord; 2019 Feb; 4(1):28-34. PubMed ID: 35382147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma.
    Cosnes A; Anglade MC; Revuz J; Radier C
    Br J Dermatol; 2003 Apr; 148(4):724-9. PubMed ID: 12752130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of morphea: Sensitivity of various named signs, a retrospective study.
    Jindal R; Shirazi N; Chauhan P
    Indian J Pathol Microbiol; 2020; 63(4):600-603. PubMed ID: 33154313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin imaging with high frequency ultrasound - preliminary results.
    Szymańska E; Nowicki A; Mlosek K; Litniewski J; Lewandowski M; Secomski W; Tymkiewicz R
    Eur J Ultrasound; 2000 Sep; 12(1):9-16. PubMed ID: 10996765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice gaps. The hard task of measuring cutaneous fibrosis: comment on "14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma)".
    Lott JP; Girardi M
    Arch Dermatol; 2011 Sep; 147(9):1115-6. PubMed ID: 21931058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.